IDRI Expands Board of Directors with Former FDA Leader Norman Baylor

December 19th, 2016|Press Releases|

SEATTLE | Dec. 19, 2016 FOR IMMEDIATE RELEASE: Seattle | Dec. 19, 2016 : IDRI (Infectious Disease Research Institute) is expanding its Board of Directors, comprised of international leaders in industry and academia, with the recent addition of Norman Baylor, Ph.D., who has [...]

IDRI Board Names Steve Cordial as CFO; Promotes Steve Reed to CEO

November 14th, 2016|Press Releases|

Seattle | Nov. 15, 2016 FOR IMMEDIATE RELEASE: Seattle | Nov. 15, 2016 : IDRI (Infectious Disease Research Institute) IDRI (Infectious Disease Research Institute) has named Steve Cordial, a financial executive with expertise in both nonprofit and corporate arenas, as its Chief [...]

IDRI Receives $15 Million Commitment from Eli Lilly for TB Drug Discovery

November 3rd, 2016|Press Releases|

Seattle, WA | November 3, 2016 FOR IMMEDIATE RELEASE: Seattle, WA | November 3, 2016 : IDRI's (Infectious Disease Research Institute) drug discovery efforts continue to grow with a recently awarded $7.5 million in additional funding, plus an additional $7.5 million of in-kind services, [...]

IDRI Receives NIH Grant to Develop RNA-Based Zika Virus Vaccine

October 6th, 2016|Press Releases|

SEATTLE | Oct. 6, 2016 FOR IMMEDIATE RELEASE: Seattle | Oct. 6, 2016 : IDRI (Infectious Disease Research Institute) As Zika cases continue to rise around the world -- and in the United States -- with associated increases in Guillain-Barre syndrome [...]

Merck Global Health Fellows Join IDRI to Work on Key Projects

August 1st, 2016|Press Releases|

Seattle | Aug. 1, 2016 FOR IMMEDIATE RELEASE: Seattle | Aug. 1, 2016 : IDRI (Infectious Disease Research Institute) As part of the prestigious Merck Fellowship for Global Health program, IDRI (Infectious Disease Research Institute) is hosting eight Fellows in Seattle for three [...]

IDRI Expands Board of Directors, Adding Global Development, Financial Expertise

June 21st, 2016|Press Releases|

Seattle | June 21, 2016 FOR IMMEDIATE RELEASE: SEATTLE, June 21, 2016 : IDRI (Infectious Disease Research Institute) is expanding its Board of Directors with the recent addition of Steve Cordial, a multi-disciplined financial executive with expertise in both nonprofit and corporate arenas, and [...]

IDRI Adds Viral Vaccine Development Expertise; Expands Leadership for Vaccine Development

April 14th, 2016|Press Releases|

Seattle, WA | April 14, 2016 FOR IMMEDIATE RELEASE: SEATTLE, April 14, 2016: IDRI (Infectious Disease Research Institute) is expanding its expertise in the field of viral diseases with the addition of Dan Stinchcomb, Ph.D., who has more than [...]

IDRI and Sanofi Pasteur Team with Philanthropy to Develop New Model for Vaccine Development

October 15th, 2015|Press Releases|

Seattle, WA | October 15, 2015 FOR IMMEDIATE RELEASE: Seattle, WA | October 15, 2015 : In an effort to accelerate timelines and decrease development costs of life-saving vaccines, the Infectious Disease Research Institute (IDRI) and Sanofi Pasteur today announce the establishment of [...]

RTC Fellows Join IDRI to Work on HIV Cure Initiative

September 28th, 2015|Press Releases|

Seattle, WA | Sept. 28, 2015 FOR IMMEDIATE RELEASE: SEATTLE, September 28, 2015: As part of the prestigious Merck Fellowship for Global Health, IDRI (Infectious Disease Research Institute) is hosting two Fellows – Todd Kennedy, national account executive, Merck, [...]

IDRI and Wellcome Trust Team for Tuberculosis Vaccine Trial in South Africa

September 17th, 2015|Press Releases|

Seattle, WA | September 17, 2015 FOR IMMEDIATE RELEASE: SEATTLE, September 17, 2015: Today, the Infectious Disease Research Institute (IDRI) and Wellcome Trust announce the start of a Phase 2a trial in South Africa of IDRI’s tuberculosis (TB) vaccine [...]

Load More